Organ-On-Chip Global Market 2018

Starting Price : $ 4000.00 | Pages : 105 | Published : November 2017 | SKU CODE : 2510 | Format :

Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate key physiological functions of body organs. These cells are placed in an environment which artificially replicates aspects of human body such as morphology, movement, flow, electrical stimuli and liquid gradients. The resulting device mimics human organ functions and is used to study biomedical phenomena.  

The global organ-on-chips market was valued at $34 million in 2017. North America accounted for about 60% of the global organ-on-a-chip market in 2017. The USA accounts for the dominant share of the North American market.

Human organs-on-chips (OOCs) are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip. With advances in OOC technology, drug regulatory bodies have started testing OOCs for their reliability and their use as an alternative to animal testing.

The companies covered are CN Bio Innovations, Emulate, TissUse, Mimetas, and Hurel.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The organs-on-chip market, which comes under the pharmaceuticals market or the consumer goods market, is segmented by organ type as: Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip and Other Organ Models.

Lung-on-chip is mainly used to study airway closure and opening, lung inflammation, airway protein synthesis or pulmonary absorption.

Heart-on-chip is used for measuring the stresses, electrophysiology and cellular architecture of the heart.

Liver-on-chip is one of the most versatile organ models available commercially. Some liver disease models are also commercially available; these include CN-Bio’s Quantam-B, a hepatitis-B model. The specific disease models on chips can be used for screening and evaluation of drug molecules for specific diseases.

Intestine-on-chip model is used to provide a physiological estimate of a drug’s absorption and metabolism in humans and study inflammatory bowel diseases of the GI tract in an accurate microenvironment.

Kidney-on-chip is mainly used to test the toxic effects of drugs on kidneys and also to evaluate the important pharmacokinetic parameters and elimination characteristics of a drug molecule.

Skin-on-chip model represents human skin physiology and is used for risk assessment and drug efficacy testing.

Blood-Brain-Barrier-On-Chip model is used to understand and treat several neurological diseases and brain disorders such as Alzheimer’s and Parkinson’s disease.

Other Organ Models primarily include multi organ-on-chip models, human-on-chip models, tumor models and custom organ models.

Next-gen Biologics- The Way Forward

The Telemedicine Technology Market Will More Than Double by 2022

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)